Key player · Company profile
Dexcom, Inc.
Named as a key player in 198 of our reports, across 33 regions and countries.
Named as a key player in 198 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 6
Brazil 6
Canada 6
China 6
Ecuador 6
Egypt 6
France 6
Germany 6
Hong Kong 6
India 6
Italy 6
Japan 6
Kenya 6
Malaysia 6
Mexico 6
New Zealand 6
Philippines 6
Russia 6
Saudi Arabia 6
Singapore 6
South Africa 6
Spain 6
Thailand 6
UAE 6
UK 6
US 6| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Diabetes Management | Pharmaceuticals | $78 Bn | 7.1% |
| Diabetes Care Devices | Medical Devices | $42.6 Bn | 5.9% |
| Werable Healthcare Devices | Digital Health | $32.6 Bn | 19.8% |
| Digital diabetes care | Digital Health | $12.8 Bn | 19.3% |
| Insulin Patch Pumps | Medical Devices | $890 Mn | 12% |
| Digital Diabetes Management | Medical Devices | – | – |
Named as key players in the same markets as Dexcom, Inc. (number of shared markets).
Medtronic5 shared markets
Insulet Corporation4 shared markets
Abbott Laboratories3 shared markets
Abbott2 shared markets
LifeScan, Inc.2 shared markets
Roche Diabetes Care2 shared markets
Tandem Diabetes Care2 shared markets
AgaMatrix Holdings LLC1 shared market